#309 Omnipod and Dexcom Updates
Juicebox Podcast: Type 1 Diabetes
00:00
OmniPot - The New B&A Worse Situation
"I couldn't be more excited about where this all is. It's tough for the casual observer to understand the big picture of it," he says. "When you tell them, nobody wants to hear it. Everybody just wants it now." The company has spent over $300 million on manufacturing in the U.S., including moving a large portion of its operations from China and going direct with European distributors.
Play episode from 01:14:20
Transcript
